维普期刊资源整合服务平台（V6.5）

58篇 您的检索式：作者名="Ready N"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Post transfusion non- cardiogenic pulmonary edema in a patient with chemotherapy-re- lated hemolytic uremic syndrome显示文摘	Kluger N J Cummings FJ Ready NE	1998	Med Health RI1998，81，7：	1
2	Highly active oligomeric (salen) Co catalysts for asymmetric epoxide ring - o- pening reactions 显示文摘	Ready J M Jacobsen E N	2001	J Am Chem Soc2001，123，11：	1
3	Organosilicone-based adjuvants effects on glyphosate efficacy and raiafastness显示文摘	Ready K N Singh M	1992	Weed Technology1992，6，2：	1
4	A practical oligomeric catalyst for asymmetric epoxide ring - o- pening reactions 显示文摘	Ready J M Jacobsen E N	2002	Angew Chem Int Ed2002，41，8：	1
5	Chemo-radiotherapy and gefinitib in stage Ⅲ Non-small Cell Lung Cancer:a CALGB stratified phase Ⅱ trial显示文摘	Ready N Janne P Herndon J	2006	J Clin Oncol2006，24，：	1
6	Gefitinib therapy for non-small cell lung cancer显示文摘	Birnbaum A Ready N	2005	Curt Treat Options Oncol2005，6，1：	1
7	Calcium and signal transduction in plants显示文摘	Poovaih A S Ready A S N	1993	Crit Rev Plant Sci1993，12，：	1
8	Risk -focused policing atplaces : An experimental evaluation 显示文摘	Weisburd D Morris N A Ready J	2008	Justice Quarterly2008，25，1：	1
9	Chemoradiotherapy and gefitinib in stage Ⅲ non-small cell lung cancer with epidermal growth factor receptor and KRAS mutation analysis:cancer and leukemia group B (CALEB) 30106,a CALGB-stratified phase Ⅱ trial显示文摘	Ready N Janne PA Bogart J	2010	J Thorac Oncol2010，5，9：	1
10	CALGB 30306:A phase II study of cisplatin(C),irinotecan(I),and bevacizumab(B)for untreated extensive stage small cell lung cancer(ES-SCLC)显示文摘	Ready N Dudek AZ Wang XF	2007	J Clin Oncol2007，25，40：	1
11	Gefitinib therapy for non-small cell lung cancer显示文摘	Bimbaum A Ready N	2005	Curr Treat Options Oncol2005，6，1：	1
12	Induction or consolidation systemic therapy in muhimodality treatment of unresectable locally advanced non small cell lung cancer显示文摘	Ready N E Vokes E E	2003	Lung Cancer2003，42，2：	1
13	Serial changes in the expression of CXCR3 and CCR5 on peripheral blood lymphocytes following human renal transplantation 显示文摘	Inston N Drayson M Ready A	2007	Exp Clin Transplant2007，5，2：	1
14	Initial cohort toxicity evaluation for chemoradiotherapy (CRT) and ZD1839 in stage Ⅲ non-small cell lung cancer (NSCLC) : A CALGB stratified phase Ⅱ trial 显示文摘	Ready N Herndon J Vokes E	2004	Journal of Clinical Oncology2004，22，14：	1
15	Serial changes in the expression of CXCR3 and CCR5 on peripheral blood lymphocytes following human renal transplantation显示文摘	Inston N Drayson M Ready A	2007	Exp Clin Transplant2007，5，2：	1
16	Control of trans- verse cracking in special quality slabs显示文摘	Pradhan N BanerjeeB N ReAdy B	2001	Ironmaking and Steelmaking2001，28，4：	1
17	A practical oligomeric catalyst for asymmetric epoxide ring-opening reactions显示文摘	READY J M JACOBSEN E N	2002	Angew Chem Int Ed2002，41，8：	1
18	Gefitinib therapy for non-small cell lung cancer显示文摘	Birnbaum A Ready N	2005	Curr Treat Options Oncol2005，6，1：	1
19	Initial cohort toxicity evaluation for chemoradiotherapy (CRT) and ZD1839 in stage Ⅲ non-small cell lung cancer (NSCLC):A CALGB stratified phase Ⅱ trial显示文摘	Ready N Herndon J Vokes E	2004	Proc Am Soc Cin Onocl2004，22，：	1
20	Gefitinib therapy for non-small cell lung cancer显示文摘	Birnbaum A Ready N	2005	Curr Treat Options Oncol2005，6，1：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示